Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics.

NCT01440634 | Completed Results

• 1 other identifier: 0830128N
• Study Type: interventional
• Target: 347
• Locations: 1 country
• Sites: 1

Brief Summary

Peripheral Arterial Disease (PAD) is a highly prevalent public health problem that results from progressive atherosclerosis of arteries in the lower extremities. PAD is also associated with major detrimental effects on quality of life and functional status, and is the most important cause of limb amputation. More importantly, PAD is a major manifestation of cardiovascular disease and a potent predictor of myocardial infarction, stroke and death. Despite its frequent occurrence, little is known about the natural history of PAD in Hispanics who represent 12.5% of the United States. Because access to health care is limited among Hispanics, CBPR is the ideal process to reach this target population. The goal of the proposed study is to evaluate community-based strategies of detection and treatment of peripheral arterial disease (PAD) in Hispanics. The proposed project consists of two phases: a cross-sectional phase (PAD detection), followed by a randomization phase.During the PAD detection study , the prevalence and severity of PAD in this population will be determined. Specific risk factors associated with PAD among the Hispanic participants will be identified. During the second phase patients will be enrolled in a randomized, non-blinded trial comparing a community-based risk factor modification and supervised exercise program versus usual care for PAD. These individuals will undergo a baseline evaluation similar to the one obtained during the first phase of the study, but will also include functional testing of the lower extremities.

Conditions

Peripheral Arterial Disease

Keywords

Peripheral arterial disease; Community Medicine; Exercise Test; Exercise Therapy

Outcome Measures

Primary Outcomes (1)

• Effect of an Exercise Intervention on Walking Ability (Functional Outcome)

  Walking distance (Six-Minute Walk test). Following a standardized protocol, individuals are instructed to walk back and forth a 100-ft hallway as far as they can in six minutes after instructions to cover as much distance as possible. A research assistant walks slightly behind each participant so as not to pace the individual. The research assistant records whether or not each person stops during the 6-minute walk. During the proposed study, members of the research team and trained lay health promoters (LHPs) will walk directly behind the individuals and give standardized instructions of encouragement at set intervals. Data will be reported on meters walked.

  6 months

Study Arms (2)

supervised exercise

OTHER

It consists of six months of supervised, intermittent track walking to near maximal leg pain or discomfort three days per week. Walking duration will begin at 20 - 30 minutes per session for the first month of the program, and increased by 5 minutes per session per month until a total of 45 minutes of walking per session is reached by the third month.

Other: Supervised exercise Program

Standard of Care

NO INTERVENTION

Patients will be observed during the time of the study, no intervention will be applied. Patients are allowed to do their regular activity at home.

Interventions

Supervised exercise Program OTHER

Supervised exercise Program consist of six months of supervised, intermittent track walking. Walking duration will begin at 20 - 30 minutes per session for the first month of the program, and increased by 5 minutes per session per month until a total of 45 minutes of walking per session is reached by the third month. During each exercise session, individuals will be encouraged to walk at a speed of approximately 2 mph until they achieve leg pain or discomfort on walking of moderate severity.Individuals are then allowed to have a brief period of standing or sitting rest to permit symptoms to resolve before they resume exercise.

supervised exercise

Eligibility Criteria

• Age: 70 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Cross-Sectional phase:
• Hispanic men and women aged 70 years or older.
• Hispanic participants with diabetes mellitus or smokers aged 50 through 69 years.
• Individual has been informed of the nature, procedures and risks of the study, and has signed a consent form approved by UT Southwestern Institutional Review Board.
• Randomization phase:
• Hispanic men and women aged 70 years or older
• English or Spanish speaking
• Hispanic participants with diabetes mellitus or smokers aged 50 through 69 years.
• Documented peripheral arterial disease with an Ankle-brachial index (ABI) \< 0.9 or Toe-brachial index (TBI) \<0.7, and abnormal Pulse Volume Recordings (PVR).
• Ability to ambulate independently.
• No prior amputations other than toe or partial foot amputations that do not impede walking.
• Patient has been informed of the nature, procedures and risks of the study, and has signed a consent form approved by the UT Southwestern Institutional Review Board.

You may not qualify if:

• Cross-Sectional Phase
• Individuals with severe dementia.
• Individuals with inability to provide informed consent.
• Bilateral lower or upper extremities amputations.
• Pregnancy or lactation. Randomization Phase
• Non-ambulatory
• Individuals with prior below- or above-knee amputations
• Individuals unable to give informed consent
• Individuals unwilling to perform the functional tests or quality of life assessments
• Individuals unable to perform exercise therapy, functional tests or quality of life assessments due to severe comorbidities
• Presence of concurrent illness with an anticipated life expectancy less than six months
• Individuals with planned operative interventions

Sponsors & Collaborators

• University of Texas Southwestern Medical Center: lead

Study Sites (1)

UT Southwestern Medical Center

Dallas, Texas, 75390, United States

Location

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

Atherosclerosis; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Cardiovascular Diseases; Peripheral Vascular Diseases

Limitations and Caveats

This study was limited by the lack of patients compliance to follow the schedule for the exercise sessions. Patients did not assisted regularly to the walking sessions, and the schedule was completed in 70 % of the plan.

Results Point of Contact

• Title: Dr. Carlos H Timaran
• Organization: UT Southwestern Medical Center

timaran1@msn.com

2146450533

Study Officials

• Carlos H Timaran, MD

  University of Texas Southwestern Medical Center

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor of Surgery

Study Record Dates

• First Submitted: September 22, 2011
• First Posted: September 26, 2011
• Study Start: February 1, 2008
• Primary Completion: February 1, 2013
• Study Completion: February 1, 2013
• Last Updated: December 29, 2015
• Results First Posted: March 28, 2014

Record last verified: 2015-11

Locations

US (1)